Table 2.
CMV – Commercial panel - Single replicate of each dilution at each site | |||||
Expected copies/ml (log10 copies/ml) | Negative | Positive* | Quantifiable | Mean (log10 copies/ml) | Range (log10 copies/ml) |
0 | 5 | ||||
500 (2.7) | 1 | 4 | |||
5000 (3.7) | 1 | 4 | 3.34 | 3.07–3.52 | |
50,000 (4.7) | 5 | 4.26 | 4.01–4.49 | ||
500,000 (5.7) | 5 | 5.19 | 4.94–5.53 | ||
CMV – WHO International Standard, three replicates of each dilution at each site | |||||
Expected IU/ml (log10 IU/ml) | Negative | Positive* | Quantifiable | Mean (log10 copies/ml) | Range (log10 copies/ml) |
0 | 15 | ||||
5 (0.7) | 13 | 2 | |||
50 (1.7) | 10 | 5 | |||
500 (2.7) | 12 | 3 | 2.42 | 2.27–2.52 | |
5000 (3.7) | 1 | 14 | 3.46 | 3.23–3.81 | |
50,000 (4.7) | 15 | 4.54 | 4.33–4.85 | ||
500,000 (5.7) | 15 | 5.61 | 5.36–5.81 |
Positive but below the reportable range